The aluminium content of bone, and mortality risk [2]

Age and Ageing

Volumn 37, Issue 2, 2008, Pages 217-220

  Hellström, Hans Olov ^a   Michaëlsson, Karl ^a   Mallmin, Hans ^a   Mjöberg, Bengt ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NONE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM;

ADOLESCENT; ADULT; AGED; ALUMINUM OVERLOAD; BONE BIOPSY; CONTROLLED STUDY; DEATH; FEMALE; FEMUR SHAFT FRACTURE; HIGH RISK POPULATION; HIP ARTHROPLASTY; HIP FRACTURE; HIP OSTEOARTHRITIS; HUMAN; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL RATE; TIBIA FRACTURE; TOXICOKINETICS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALUMINUM; BONE AND BONES; BONE DENSITY; COHORT STUDIES; FEMALE; FEMORAL FRACTURES; FRACTURES, BONE; GERIATRIC ASSESSMENT; HIP FRACTURES; HUMANS; MALE; MORTALITY; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SWEDEN; TIBIAL FRACTURES;

EID: 41249088551     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afm152     Document Type: Letter

References (27)

1. Ganrot PO. Metabolism and possible health, effects of aluminum. Environ Health Perspect 1986; 65: 363-441.
2. Alfrey AC. Aluminum metabolism and toxicity in uremia. J UOEH 1987; (9 Suppl): 123-32.
3. Berlyne GM. Hyperaluminaemia from aluminium resins. Lancet 1970; 2: 1253.
4. Hewitt CD, Savory J, Wills MR. Aspects of aluminum toxicity. Clin Lab Med 1990; 10: 403-22.
5. Cannata-Andia JB, Fernandez-Martin JL. The clinical impact of aluminium overload in renal failure. Nephrol Dial Transplant 2002; 17(Suppl. 2): 9-12.
6. Nebeker HG, Coburn JW. Aluminum and renal osteodystrophy. Annu Rev Med 1986; 37: 79-95.
7. Ward MK, Feest TG, Ellis HA et al. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium. Lancet 1978; 1: 841-5.
8. Perl DP, Gajdusek DC, Garruto RM et al. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 1982; 217: 1053-5.
9. Yoshida S. Environmental factors in western Pacific foci of ALS and a possible pathogenetic role of aluminum (Al) in motor neuron degeneration. Rinsho Shinkeigaku 1991; 31: 1310-2.
10. Hollosi M, Shen ZM, Perczel A et al. Stable intrachain and interchain complexes of neurofilament peptides: A putative link between A13+ and Alzheimer disease. Proc Natl Acad Sci U S A 1994; 91: 4902-6.
11. Lukiw WJ, Krishnan B, Wong L et al. Nuclear compartmentalization of aluminum in Alzheimer's disease (AD). Neurobiol Aging 1992; 13:115-21.
12. Murayama H, Shin RW, Higuchi J et al. Interaction of aluminum with PHFtau in Alzheimer's disease neurofibrillary degeneration evidenced by desferrioxamine-assisted chelating autoclave method. Am J Pathol 1999; 155: 877-95.
13. Alfrey AC. Aluminum. Adv Clin Chem 1983; 23: 69-91.
14. Varo P, Koivistoinen P. Mineral element composition of Finnish foods. Acta Agric Scand 1980; 22: 161-71.
15. Priest ND. Alummium. Occurrence and toxicity. In: Sadler JJ, Caballero B. eds. Encyclopedia of Human Nutrition. San Diego, CA:ACademic Press, 1999; 59-66.
16. Priest ND. The biological behaviour and bioavailability of aluminium in man, with special reference to studies employing aluminium-26 as a tracer: Review and study update. J Environ Monit 2004; 6: 375-403.
17. Moore PB, Day JP, Taylor GA et al. Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord 2000; 11: 66-9.
18. Taylor GA, Ferrier IN, McLoughlin IJ et al. Gastrointestinal absorption of aluminium in Alzheimer's disease: Response to aluminium citrate. Age Ageing 1992; 21: 81-90.
19. Hellstrom HO, Mjoberg B, Mallmin H et al. The aluminum content of bone increases with age, but is not higher in hip fracture cases with and without dementia compared to controls. Osteoporos Int 2005; 16: 1982-8.
20. Hellstrom HO, Lindb U, Mjoberg B. Measurement accuracy of aluminium content in bone. Ups J Med Sci 2000; 105: 67-71.
21. Bharathi, Jagannatha Rao KS, Stein R. First evidence on induced topological changes in supercoiled DNA by an aluminium D-aspartate complex. J Biol Inorg Chem 2003; 8: 823-30.
22. Latha KS, Anitha S, Rao KS et al. Molecular understanding of aluminum-induced topological changes in (CCG)12 triplet repeats: relevance tc neurological disorders. Biochim Biophys Acta 2002; 1588: 56-64.
23. Lukiw WJ, LeBlanc HJ, Carver LA et al. Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease. J Mol Neurosci 1998; 11: 67-78.
24. Ghribi O, DeWitt DA, Forbes MS et al. Co-involvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminum-treated rabbits. Brain Res 2001; 903: 66-73.
25. Ghribi O, Herman MM, Savory J. The endoplasmic reticulum is the main site for caspase-3 activation following aluminum-induced neurotoxicity in rabbit hippocampus. Neurosci Lett 2002; 324: 217-21.
26. Griffioen KJ, Ghribi O, Fox N et al. Aluminum maltolate-induced toxicity in NT2 cells occurs through apoptosis and includes cytochrome c release. Neurotoxicology 2004; 25: 859-67.
27. Yang SJ, Lee JE, Lee KH et al. Opposed regulation of aluminum-induced apoptosis by glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor in rat brains. Brain Res Mol Brain Res 2004; 127: 146-9.